Source: Eur Respir J 2012; 40: 1300-1303



Rating:

Share or cite this content

Citations should be made in the following way:
Helen J. Boyle, Gérard Chatté, Michel Rivoire, Aude Fléchon. Lung toxicity in a patient treated with sunitinib. Eur Respir J 2012; 40: 1300-1303

Member's Comments

No comment yet.

Related content which might interest you: Survival in 138 patients with non small cell lung cancer (NSCLC) treated with platinum together with gemcitabine or vinorelbine by a multidisciplinary team. Comparison with the Big Lung Trial Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 Effectiveness of oral metronomic Vinorelbine versus Docetaxel as second-line treatment in Non-Small Cell Lung Cancer patients in real life Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 A prospective study on lung toxicity in patients treated with paclitaxel and carboplatin Source: Eur Respir J 2001; 18: Suppl. 33, 377s Year: 2001 Survival and respiratory effects in NSCLC patients after treatment with inhaled carboplatin Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients Source: Eur Respir Rev 2013; 22: 93-95 Year: 2013 Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 A phase II trial of lipoplatin and gemcitabine in patients with NSCLC previously treated with platinum-based chemotherapy Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Clinical experiences of amrubicin hydrochloride monotherapy in extensive-disease small cell lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Clinical outcome of S-1 monotherapy in patients with advanced non-small cell lung cancer after treatment of pemetrexed Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Combination of erlotinib and bevacizumab in non small cell lung cancer patients Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006 Phase I trial of pemetrexed, carboplatin and sorafenib as first-line treatment in patients with metastatic NSCLC Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of lung metastases Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004 Tobacco exposure and survival in non small cell lung cancer patients treated with erlotinib Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Consolidation maintenance oral vinorelbine following concurrent chemoradiation of intravenous vinorelbine and cisplatin in patients with unresectable stage III non-small cell lung cancer Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 434s Year: 2007